218 related articles for article (PubMed ID: 3745409)
1. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.
Schlumberger M; Tubiana M; De Vathaire F; Hill C; Gardet P; Travagli JP; Fragu P; Lumbroso J; Caillou B; Parmentier C
J Clin Endocrinol Metab; 1986 Oct; 63(4):960-7. PubMed ID: 3745409
[TBL] [Abstract][Full Text] [Related]
2. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables.
Ruegemer JJ; Hay ID; Bergstralh EJ; Ryan JJ; Offord KP; Gorman CA
J Clin Endocrinol Metab; 1988 Sep; 67(3):501-8. PubMed ID: 3410936
[TBL] [Abstract][Full Text] [Related]
3. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
6. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.
Bernier MO; Leenhardt L; Hoang C; Aurengo A; Mary JY; Menegaux F; Enkaoua E; Turpin G; Chiras J; Saillant G; Hejblum G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1568-73. PubMed ID: 11297585
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
11. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.
Pittas AG; Adler M; Fazzari M; Tickoo S; Rosai J; Larson SM; Robbins RJ
Thyroid; 2000 Mar; 10(3):261-8. PubMed ID: 10779141
[TBL] [Abstract][Full Text] [Related]
12. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
Kloos RT; Mazzaferri EL
J Clin Endocrinol Metab; 2005 Sep; 90(9):5047-57. PubMed ID: 15972576
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results.
Niederle B; Roka R; Schemper M; Fritsch A; Weissel M; Ramach W
Surgery; 1986 Dec; 100(6):1088-97. PubMed ID: 3787464
[TBL] [Abstract][Full Text] [Related]
14. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
15. [Management of lung and bone metastases from thyroid cancers of differentiated structures].
Lukács G; Balázs G; Uray E; Juhász F
Orv Hetil; 1991 Nov; 132(47):2587-90. PubMed ID: 1956681
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome.
Hindié E; Zanotti-Fregonara P; Keller I; Duron F; Devaux JY; Calzada-Nocaudie M; Sarfati E; Moretti JL; Bouchard P; Toubert ME
Endocr Relat Cancer; 2007 Sep; 14(3):799-807. PubMed ID: 17914109
[TBL] [Abstract][Full Text] [Related]
17. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma.
Choi YM; Kim WG; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Hong EG; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2016 Sep; 175(3):165-72. PubMed ID: 27272238
[TBL] [Abstract][Full Text] [Related]
18. Death from differentiated thyroid carcinoma: retrospective study of a 40-year investigation.
Ronga G; Filesi M; Montesano T; Melacrinis FF; Di Nicola A; Ventroni G; Antonaci A; Vestri AR
Cancer Biother Radiopharm; 2002 Oct; 17(5):507-14. PubMed ID: 12470420
[TBL] [Abstract][Full Text] [Related]
19. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
20. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
